BacPathLiv Profile Banner
BacPathLiverpool Profile
BacPathLiverpool

@BacPathLiv

Followers
474
Following
688
Media
47
Statuses
644

Bacterial Pathogenesis & Immunity group led by Aras Kadioglu. We work on host-pneumococcal interactions; carriage & transmission, co-infections, Tregs, vaccines

Liverpool, UK
Joined June 2019
Don't wanna be here? Send us removal request.
@BacPathLiv
BacPathLiverpool
3 years
Fellowship candidates! Want to join us and work on pneumococcus, GAS, GBS or Pseudomonas aeruginosa? Interested in host pathogen interactions, infection immunology and vaccine research? Get in touch! We can discuss projects and sponsorship of your fellowship proposal.
0
20
35
@ThePandemicInst
The Pandemic Institute
8 months
Did you know we have a Pre-Clinical Studies Unit? It offers clinically relevant models of infection and disease for testing new vaccine candidates, drugs and therapies. Find out more here: https://t.co/OESQEvzJoe
0
3
2
@BacPathLiv
BacPathLiverpool
9 months
Great PhD student, a joy to supervise and work with. Looking forward to continued collaboration.
@tiraput_p
Tiraput P
9 months
PhDone
2
1
3
@BacPathLiv
BacPathLiverpool
11 months
This was a great collaboration spanning 3 continents (!) and led very successfully by @ShadiaKhandaker - very interesting results too!
@ShadiaKhandaker
Shadia Khandaker
11 months
How does immune response diversity impact babies' defence against Group B Strep? Our study shows key differences in women from Bangladesh, the UK & Malawi. Could this influence global GBS vaccine strategies? https://t.co/dtXl5meS1d #GBS #VaccineResearch #GlobalHealth @BacPathLiv
0
1
2
@BacPathLiv
BacPathLiverpool
11 months
Interested in doing a PhD on mechanisms of pneumococcal host-to-host transmission? We have a fully funded PhD available now, deadline 26 January. Come and join us!
Tweet card summary image
findaphd.com
PhD Project - Deciphering mechanisms of host-to-host transmission in pathogenesis of pneumococcal disease at University of Liverpool, listed on FindAPhD.com
0
8
7
@wfigueroac3
Wendy Figueroa
11 months
🚨New paper alert🚨 So happy to finally share this! now out @CellReports ✨ We explored the hierarchical structure that controls virulence in Pseudomonas🦠, finding a mutational hotspot that acts as a genetic switch for hypervirulence💀 and AMR💊
Tweet card summary image
cell.com
Regulatory systems behind antimicrobial resistance and virulence are poorly understood. Figueroa et al. show that the mutational state of the Pseudomonas aeruginosa regulator mexT acts as a genetic...
5
16
60
@BacPathLiv
BacPathLiverpool
1 year
Interested in phage therapy, host immunity and infection models? Join our group for fully funded PhD available now - deadline 25 November.
Tweet card summary image
findaphd.com
PhD Project - Delivery Strategies in Phage Therapy: Balancing Host Responses and Therapeutic Efficacy at University of Liverpool, listed on FindAPhD.com
0
1
3
@BacPathLiv
BacPathLiverpool
1 year
We’re moving! Please follow us on ⁦@BacPathLiv⁩.bsky.social see you there!
0
1
1
@BacPathLiv
BacPathLiverpool
1 year
Join our group for exciting new PhD project on “Ageing-related susceptibility to pneumococcal pneumonia” MRC DiMeN Doctoral Training Partnership. Deadline 13 Dec.
Tweet card summary image
findaphd.com
PhD Project - MRC DiMeN Doctoral Training Partnership: Ageing-related susceptibility to pneumococcal pneumonia at University of Liverpool, listed on FindAPhD.com
0
3
3
@MurielleB_07
Murielle B
1 year
Our publication on #GBS is out in @JournalSpectrum!!! Congratulations everyone!👏🎉👏 👉The Streptococcus agalactiae LytSR two-component regulatory system promotes vaginal colonization and virulence in vivo | Microbiology Spectrum https://t.co/Yjp7mG1TzP @BacPathLiv @LivUni_IVES
Tweet card summary image
journals.asm.org
Streptococcus agalactiae (group B Streptococcus, or GBS) is a common commensal of the female urogenital tract and one of WHO’s priority pathogens. The bacterium has evolved mechanisms to adapt and...
1
4
6
@MurielleB_07
Murielle B
1 year
Very happy to be back in my country 🇨🇵 and attend #MICROBES2024 @SFMicrobiologie to present my poster AN-P02 which shows how light kills #Pseudomonas #aeruginosa and #MRSA biofilms. It's my last conference for the amazing @light4lungs project 🥲 @BacPathLiv @LivUni_IVES
0
1
2
@NIHRglobal
NIHR Global Health
1 year
We are inviting applications to our Global Health Research (GHR) – Researcher-led programmes’ first annual funding opportunity! Learn more about GHR – Researcher-led, watch our recent webinar and start your application: https://t.co/UremYp15Kn
0
9
13
@BacPathLiv
BacPathLiverpool
1 year
Join our group and @JoJofoth to work on exciting new synthetic phage therapy project funded by @BBSRC Great opportunity to learn lots of cool techniques & models. Deadline 1 September.
0
7
5
@CarrolEnitan
Enitan Carrol 🇬🇲🇸🇱🏴󠁧󠁢󠁳󠁣󠁴󠁿🇬🇧
1 year
Proud to have contributed to this four-paper series on paediatric sepsis by a diverse and multidisciplinary group in The Lancet Child & Adolescent Health and The Lancet Digital Health. https://t.co/zMYxuEzbYp
0
8
36
@MurielleB_07
Murielle B
2 years
It works!After several attemps and a lot of frustration🤣, Giacomo and Giovanni from @UNI_FIRENZE and I set up a protocol to kill #multidrugresistant bacteria in lung tissues!Thank you @tiraput_p for our"celebration snack"🍾🥂🥳 @light4lungs @BacPathLiv @LivUni_IVES
1
1
4
@MurielleB_07
Murielle B
2 years
I was very happy to present my poster B196 "Photodynamic killing activity of Pseudomonas aeruginosa and MRSA in artificial sputum medium biofilm model" for @light4lungs consortium at @MicrobioSoc ! @BacPathLiv @LivUni_IVES
0
4
6
@jrpenades
José R Penadés
2 years
Led by @jakob_tr and @quiles_nuria, with @lasa_lab, we show that prophages utilise noncontiguous operons to balance immunity and autoimmunity. Our results underscore the essential fine regulation of these processes for prophages' life cycle development. https://t.co/XFI0iSfgkJ
Tweet card summary image
nature.com
Nature Microbiology - Prophage-encoded anti-phage defence systems in Staphylococcus aureus protect hosts from superinfection but also prevent autoimmunity via an overlapping gene.
2
46
114